Cancer Prevention and Control Clinical Trials Grant Program
Funds an investigator's own cancer trial in early detection, screening, prevention, care delivery, quality of life or survivorship — not diagnosis or therapy.
Most cancer trial money goes on treating people who already have cancer. This notice funds the rest of the field, and draws a hard line around itself.
The National Cancer Institute names six areas: early detection, screening, prevention and interception, healthcare delivery, quality of life, and survivorship. A trial has to reduce the burden of cancer through one of them, and it has to be capable…
Investigator-initiated clinical trials reducing cancer burden through early detection, screening, prevention and interception, healthcare delivery, quality of life or survivorship, of programmatic interest to the Division of Cancer Prevention or the Division of Cancer Control and Population Sciences. Trials of cancer diagnosis or oncologic therapy in patients are excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up